rxstat › Shortages › Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis

Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis (Adacel) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis has no current shortage reported in Canada. It has been in shortage before; the history is below.

A vaccine used to protect against tetanus, diphtheria, and whooping cough (pertussis).

Products affected

0 / 1

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

ADACEL

5LF 5MCG 3MCG 5MCG 2LF 2.5MCG · SUSPENSION · SANOFI VACCINES CANADA LTD.

DIN 02240255 · ended Jun 24, 2026

Resolved

ADACEL

5LF 5MCG 3MCG 2LF 5MCG 2.5MCG · SUSPENSION · Sanofi Vaccines Canada Ltd

DIN 02240255 · ended Feb 6, 2026 · Due to delays in the product release process. Supply planning is underway to continue to meet the Public market demand. Product not available for private market

reversed

ADACEL

5MCG 5LF 2LF 3MCG 2.5MCG 5MCG · SUSPENSION · SANOFI PASTEUR LIMITED

DIN 02240255

Resolved

ADACEL

5MCG 2.5MCG 3MCG 2LF 5LF 5MCG · SUSPENSION · SANOFI PASTEUR LIMITED

DIN 02240255 · ended Sep 29, 2020

What's happening

There are no active shortage reports for Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis. Health Canada has 4 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis is classified under “BACTERIAL VACCINES” (ATC J07AJ).

Recent changes

No changes recorded yet.

Common questions

What is Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis used for?

A vaccine used to protect against tetanus, diphtheria, and whooping cough (pertussis).

When will Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis be back in stock in Canada?

Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis has no active shortage; supply is normal per Health Canada reports.

Why is Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Haemagglutinin Diphtheria Toxoid Pertussis in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (bacterial vaccines)

Boostrix (Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussi…) Partial shortage 1 of 1 reported products affected · est. return Aug 31, 2026 Menveo (Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Gr…) No current shortage Prevnar (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) Discontinued 0 of 1 reported products affected Capvaxive (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) No current shortage Hiberix (Haemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate) Discontinued 0 of 1 reported products affected Menjugate (Meningococcal Group C Oligosaccharide Corynebacterium Diphth…) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.